DexCare, a digital health company, has raised $20 million investment led by Define Ventures.
The company said other investors include Frist Cressey Ventures, Kaiser Permanente Ventures, SpringRock Ventures and Providence Ventures.
DexCare, a Platform-as-a-Service (PaaS), is an intelligent digital care operating system that manages health system capacity and demand across all lines of care. It has secured half a dozen customers, including Community Health Network, the Froedtert and the Medical College of Wisconsin health network, Houston Methodist, and Providence.
Dexcare is the third technology incubated by the Providence Digital Innovation Group. The first was Xealth which enables clinicians to prescribe and monitor digital health content, apps and services as easily as they do medications or orders today. Xealth was spun out of Providence in 2017. The second was Circle, a women’s health technology company, that was sold to Wildflower Health in 2018.